GMP Update: Reducing Obstacles to Innovation

October 2, 2003

Jill Wechsler

Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-10-02-2003, Volume 27, Issue 10

FDA offers new policies to encourage modern manufacturing approaches and automated systems, to simplify postapproval changes, and to avoid problems with sterile products.

Related Content:

Regulatory/GMP ComplianceRegulatory WatchPharmaceutical Technology-10-02-2003

FDA Inspections During COVID-19: A Brave New World

FDA Inspectors Cited Critical Problems at Emergent Facility

Pressure Mounts for FDA to Ramp Up Drug Inspections